Back to News list

The NHS Fife Board has approved the full business case for a new electronic prescribing and medicines administration system. This will improve patient safety by transforming the way medicines are prescribed and administered in Fife’s hospitals. 

Most medicines used in hospitals are still prescribed and administered using a paper-based chart system, and with the increasing range and complexities of medicines available the safe and effective prescribing and administration of medicines is increasingly challenging. 

The Hospital Electronic Prescribing and Medicines Administration System (HEPMA) is designed to replace existing paper-based systems and make prescribing and administration processes more efficient, freeing up clinical staff to carry out face-to-face care.  

Prescribing decisions for individual patients will be improved by giving prescribers access to a complete medication prescribing and administration record containing up-to-date historical and current information. The HEPMA software will also improve patient safety by producing real-time alerts to inform prescribers of previous drug allergies or adverse drug reactions reported for the patient.  

Electronic prescribing is the last major area of clinical information not available electronically and the new system will effectively ensure patients in Fife have a complete electronic health record. 

Pending formal approval from Scottish Government, the implementation of HEPMA within NHS Fife will take around 36 months to complete across all hospitals in the  KingdomThe cost to implement the system is £2.5m which will be delivered  over three year period 

NHS Fife Medical Director, Dr Chris McKenna, said the development. 

“The approval of the business case is an important milestone in the development of an electronic prescribing system in our hospitals. 

“The HEPMA system will enable greater control over what medicines are prescribed, how they are prescribed and how they are administered. The system will also enable the early identification of high-risk patients, allowing clinical staff to act much earlier in order to prevent patient from deteriorating. 

Crucially, as more and more patients are treated with complex therapies, the system will reduce the opportunity for human error and ultimately improve patient safety as a result. “ 

Issued: 25 November 2020